Search Results - "Wu, Alan"

Refine Results
  1. 1

    Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled by Oh, Sam S, Galanter, Joshua, Thakur, Neeta, Pino-Yanes, Maria, Barcelo, Nicolas E, White, Marquitta J, de Bruin, Danielle M, Greenblatt, Ruth M, Bibbins-Domingo, Kirsten, Wu, Alan H B, Borrell, Luisa N, Gunter, Chris, Powe, Neil R, Burchard, Esteban G

    Published in PLoS medicine (01-12-2015)
    “…Esteban Gonzalez Burchard and colleagues explore how making medical research more diverse would aid not only social justice but scientific quality and clinical…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Cardiac Troponin and Outcome in Acute Heart Failure by Peacock, W. Frank, De Marco, Teresa, Fonarow, Gregg C, Diercks, Deborah, Wynne, Janet, Apple, Fred S, Wu, Alan H.B

    Published in The New England journal of medicine (15-05-2008)
    “…In this large, retrospective registry study, patients hospitalized with acute decompensated heart failure who had elevated cardiac troponin levels had higher…”
    Get full text
    Journal Article
  4. 4

    Sex-Specific 99th Percentile Upper Reference Limits for High Sensitivity Cardiac Troponin Assays Derived Using a Universal Sample Bank by Apple, Fred S, Wu, Alan H B, Sandoval, Yader, Sexter, Anne, Love, Sara A, Myers, Gary, Schulz, Karen, Duh, Show-Hong, Christenson, Robert H

    Published in Clinical chemistry (Baltimore, Md.) (01-03-2020)
    “…How to select healthy reference subjects in deriving 99th percentiles for cardiac troponin assays still needs to be clarified. To assist with global…”
    Get full text
    Journal Article
  5. 5

    Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection by Zhang, Yu, Ong, Chui Mei, Yun, Cassandra, Mo, Weike, Whitman, Jeffery D, Lynch, Kara L, Wu, Alan H B

    Published in Clinical chemistry (Baltimore, Md.) (01-01-2022)
    “…Abstract Background Biomarkers have been widely explored for coronavirus disease 2019 diagnosis. Both viral RNA or antigens (Ag) in the respiratory system and…”
    Get full text
    Journal Article
  6. 6

    Biological variation of galectin-3 and soluble ST2 for chronic heart failure: Implication on interpretation of test results by Wu, Alan H.B., PhD, DABCC, Wians, Frank, PhD, DABCC, Jaffe, Allan, MD

    Published in The American heart journal (01-06-2013)
    “…Background Galectin-3 and soluble ST2 (sST2) are novel serum biomarkers of chronic heart failure. Methods and Results The biological variability of galectin-3…”
    Get full text
    Journal Article
  7. 7

    A SARS-CoV-2 Label-Free Surrogate Virus Neutralization Test and a Longitudinal Study of Antibody Characteristics in COVID-19 Patients by Luo, Yiqi Ruben, Yun, Cassandra, Chakraborty, Indrani, Wu, Alan H B, Lynch, Kara L

    Published in Journal of clinical microbiology (18-06-2021)
    “…Methods designed to measure severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) humoral response include virus neutralization tests to determine…”
    Get full text
    Journal Article
  8. 8

    Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Avidity Maturation and Association with Disease Severity by Luo, Yiqi Ruben, Chakraborty, Indrani, Yun, Cassandra, Wu, Alan H B, Lynch, Kara L

    Published in Clinical infectious diseases (02-11-2021)
    “…Abstract The kinetics of IgG avidity maturation during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was studied. The IgG avidity…”
    Get full text
    Journal Article
  9. 9

    Clinical and biomarker predictors of side effects from tamoxifen by Lorizio, Wendy, Wu, Alan H. B., Beattie, Mary S., Rugo, Hope, Tchu, Simone, Kerlikowske, Karla, Ziv, Elad

    Published in Breast cancer research and treatment (01-04-2012)
    “…Tamoxifen decreases breast cancer recurrence, mortality, and breast cancer risk in high-risk women. Despite these proven benefits, tamoxifen use is often…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Development of Label-Free Immunoassays as Novel Solutions for the Measurement of Monoclonal Antibody Drugs and Antidrug Antibodies by Luo, Yiqi Ruben, Chakraborty, Indrani, Lazar-Molnar, Eszter, Wu, Alan H B, Lynch, Kara L

    Published in Clinical chemistry (Baltimore, Md.) (01-10-2020)
    “…Immunoassays based on label-free technologies (label-free immunoassay [LFIA]) offer an innovative approach to clinical diagnostics and demonstrate great…”
    Get full text
    Journal Article
  12. 12

    99th Percentile Upper-Reference Limit of Cardiac Troponin and the Diagnosis of Acute Myocardial Infarction by Sandoval, Yader, Apple, Fred S, Saenger, Amy K, Collinson, Paul O, Wu, Alan H B, Jaffe, Allan S

    Published in Clinical chemistry (Baltimore, Md.) (01-09-2020)
    “…Abstract Background Concerns exist regarding how the 99th percentile upper reference limit (URL) of cardiac troponin (cTn) is determined and whether it should…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Interpreting Laboratory Results in Transgender Patients on Hormone Therapy by Roberts, Tiffany K., PhD, Kraft, Colleen S., MD, French, Deborah, PhD, Ji, Wuyang, Wu, Alan H.B., PhD, Tangpricha, Vin, MD, PhD, Fantz, Corinne R., PhD

    Published in The American journal of medicine (01-02-2014)
    “…Abstract Background Clinical guidelines recommend laboratory monitoring of transgender persons on cross-sex hormone therapy, but gender-specific reference…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Implementation of liquid chromatography/mass spectrometry into the clinical laboratory by Wu, Alan H.B., French, Deborah

    Published in Clinica chimica acta (01-05-2013)
    “…For certain clinical chemistry and toxicology analytes, liquid chromatography (LC) coupled with tandem mass spectrometry (MS/MS) offers significant advantages…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Evaluation of SARS-CoV-2 serology assays reveals a range of test performance by Whitman, Jeffrey D., Hiatt, Joseph, Mowery, Cody T., Shy, Brian R., Yu, Ruby, Yamamoto, Tori N., Rathore, Ujjwal, Goldgof, Gregory M., Whitty, Caroline, Woo, Jonathan M., Gallman, Antonia E., Miller, Tyler E., Levine, Andrew G., Nguyen, David N., Bapat, Sagar P., Balcerek, Joanna, Bylsma, Sophia A., Lyons, Ana M., Li, Stacy, Wong, Allison Wai-yi, Gillis-Buck, Eva Mae, Steinhart, Zachary B., Lee, Youjin, Apathy, Ryan, Lipke, Mitchell J., Smith, Jennifer Anne, Zheng, Tina, Boothby, Ian C., Isaza, Erin, Chan, Jackie, Acenas, Dante D., Lee, Jinwoo, Macrae, Trisha A., Kyaw, Than S., Wu, David, Ng, Dianna L., Gu, Wei, York, Vanessa A., Eskandarian, Haig Alexander, Callaway, Perri C., Warrier, Lakshmi, Moreno, Mary E., Levan, Justine, Torres, Leonel, Farrington, Lila A., Loudermilk, Rita P., Koshal, Kanishka, Zorn, Kelsey C., Garcia-Beltran, Wilfredo F., Yang, Diane, Astudillo, Michael G., Bernstein, Bradley E., Gelfand, Jeffrey A., Ryan, Edward T., Charles, Richelle C., Iafrate, A. John, Lennerz, Jochen K., Miller, Steve, Chiu, Charles Y., Stramer, Susan L., Wilson, Michael R., Manglik, Aashish, Ye, Chun Jimmie, Krogan, Nevan J., Anderson, Mark S., Cyster, Jason G., Ernst, Joel D., Wu, Alan H. B., Lynch, Kara L., Bern, Caryn, Hsu, Patrick D., Marson, Alexander

    Published in Nature biotechnology (01-10-2020)
    “…Appropriate use and interpretation of serological tests for assessments of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure, infection and…”
    Get full text
    Journal Article